Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,620
Closed -$1.1M 160
2024
Q2
$1.1M Buy
+9,620
New +$1.22M 0.02% 103
2024
Q1
Sell
-11,366
Closed -$1.42M 156
2023
Q4
$1.42M Sell
11,366
-4,047
-26% -$413K 0.02% 100
2023
Q3
$1.44M Sell
15,413
-10,109
-40% -$1.14M 0.03% 97
2023
Q2
$3.28M Sell
25,522
-2,647
-9% -$320K 0.07% 70
2023
Q1
$3.28M Buy
+28,169
New +$3.15M 0.07% 71

Other funds holding DXCM

ABN AMRO Bank's DXCM Position: Q3 2024 in Review

ABN AMRO Bank sold out of DexCom (DXCM) in Q3 2024, closing a stake of 9,620 shares — an estimated $1.1M sold.

ABN AMRO Bank first reported a position in DXCM in Q1 2023 and held it in 5 quarters. The position peaked at $3.28M in Q1 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • ABN AMRO Bank reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • ABN AMRO Bank sold 9,620 DexCom shares in Q3 2024, an estimated $1.1M.
  • ABN AMRO Bank first reported a position in DexCom in Q1 2023 and held it in 5 quarters.
  • ABN AMRO Bank's DexCom position peaked at $3.28M in Q1 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on ABN AMRO Bank's 13F filing for Q3 2024, filed 28 Aug 2025.